The age, creatinine, and ejection fraction (ACEF) score was introduced in 2009 and is presently included in the guidelines for myocardial revascularization of the European Society of Cardiology and Association for Cardio-Thoracic Surgery as a risk stratification tool for surgical and percutaneous myocardial revascularization. The present study introduces an updated version of the ACEF (ACEF II) inclusive of emergency surgery and pre-operative anaemia. 
Introduction
The age, creatinine, and ejection fraction (ACEF) score was introduced in 2009 as a parsimonious 30-day mortality risk score for elective adult cardiac surgery patients. 1 In 2010, it was included in the European Society of Cardiology and Association for Cardio-Thoracic Surgery guidelines on myocardial revascularization (Class IIB) 2 and confirmed this position in the 2014 update. 3 In this last version, it was included even for risk stratification in patients undergoing percutaneous coronary interventions. Following its introduction, the ACEF score was validated in numerous external series, basically confirming its accuracy and clinical applicability. [4] [5] [6] [7] [8] [9] The main point of strength of the ACEF score relies on its easiness of calculation, being based on three variables only: age (years)/left ventricular ejection fraction (EF) (%) plus one additional point if the serum creatinine value exceeds 2 mg/dL.
The main limitations of the ACEF score are its single-centre development and its applicability to elective patients only. The first limitation has been overcome by its validation in numerous external series, whereas the second 2nd remains. Additionally, the fast-changing nature of cardiac surgery procedures as well as the changes in the patient population profile (most of all the progressive ageing) and some emerging new risk factors lead to an inevitable update of the ACEF score, as already happened to other cardiac surgery risk scores like the EuroSCORE. 10, 11 , whereas in the last 5-6 years an overwhelming amount of studies have stressed its impact. [14] [15] [16] [17] [18] The second is that pre-operative anaemia is still a lacking risk factor not only in the ACEF but also in the EuroSCORE II and in the Society of Thoracic Surgeons (STS) Score. 19 
Methods
This update of the ACEF score is based on a totally new and more recent sample size than the original one. The sample size is represented by 7011 consecutive adult (>18 years) patients receiving heart surgery at our institution (IRCCS Policlinico San Donato) from 1 January 2010 to 9 November 2016. The only exclusion criteria were surgery for congenital heart defects and salvage surgery (patients requiring cardiopulmonary resuscitation en route to the operating theatre or prior to induction of anaesthesia). Heart transplantation is not included because not performed at our institution. The study was approved by the Local Ethics Committee of IRCCS San Raffaele Hospital, which waived the need for an informed consent. The study was funded by research funds of the IRCCS Policlinico San Donato, a Clinical Research Hospital partially funded by the Italian Ministry of Health.
Definitions
For the purposes of the present study, the outcome variable was the operative mortality, defined as (i) in-hospital mortality at any time or (ii) mortality after discharge but within 30 days from surgery. All the potential risk factors for operative mortality were defined according to the EuroSCORE II 12 definitions. In particular, the age was defined in completed years; the left ventricular EF was defined as percentage (%) at the most recent pre-operative assessment; serum creatinine (mg/dL) was the last one recorded before surgery, and emergency surgery was defined as operation required before the beginning of the next working day after decision to operate. This last definition exactly matches that used in the EuroSCORE II. Pre-operative anaemia was assessed based on the last haematocrit (HCT, %) value registered before induction of anaesthesia, at the standard laboratory tests. Values registered in the operating theatre using point-of-care devices were not considered.
Development of the model
The five potential predictors of operative mortality (the three already present in the ACEF and the additional emergency and anaemia factors) were preliminarily tested at a univariate analysis for association with the operative mortality. Continuous variables were tested with logistic regression equations, producing odds ratios (OR) and 95% confidence intervals (CI), and dichotomous variables with Pearson v 2 , producing relative risks and 95% CI. When feasible, receiver operating characteristics (ROC) analyses were performed, producing the c-statistics values.
For the association between HCT and operative mortality, adequate cutoff values were searched using the Youden's index (best combination of sensitivity and specificity). Once defined the critical value for pre-operative HCT, the level of anaemia was defined in terms of HCT points below this value. Subsequently, the age/EF ratio and the other four predictors were entered into a multivariable logistic regression model, to check for their independent association with operative mortality, producing OR and 95% CI.
In analogy with the development of the ACEF score, the ACEF II score was developed starting with the age/EF value and adding points based on the presence of the other risk factors (serum creatinine > 2.0 mg/dL, emergency surgery, and HCT below the critical value). The relative value of each risk condition with respect to the age/EF ratio was assessed based on the OR of each risk condition in the multivariable model.
Assessment of discrimination properties and calibration of the model
The discriminative ability of the ACEF II score was assessed using an ROC analysis with c-statistics. The c-statistics of the ACEF II score was compared with the ACEF score following the method reported by DeLong and et al. 20 in the whole patient population, and with the EuroSCORE II in a subset of 4869 patients, where both the scores were available. Calibration of the model was tested with the Hosmer-Lemeshow test and by comparing the observed and predicted operative mortality in the overall population and in different subsets of patients according to the presence of emergency surgery, anaemia, or both. This last analysis was conducted for the original ACEF score and the new ACEF II score. The scores were considered to correctly predict the observed operative mortality if the predicted operative mortality was included in the 95% CI of the observed operative mortality, and to over-or underestimate it if was respectively higher than the upper limit or lower than the lower limit of the 95% CI of the observed operative mortality. A calibration plot of the predicted vs. observed operative mortality was developed according to recent statistical suggestions for developing and validating risk scores. 21 This plot includes a linear regression analysis with assessment of the intercept with the y axis and slope, and a locally weighted scatterplot smoothing.
External validation
The ACEF II score was validated in an external series of 1687 consecutive patients operated at the Policlinico Santa Maria alle Scotte, University Hospital of Siena. All the statistical analyses were performed with computerized packages (SPSS 20.0, IBM, Chicago, IL, and MedCalc, MedCalc Software, Ostend, Belgium). A P-value < 0.05 was considered significant for all the statistical tests.
Results

ACEF II model development
Demographics, co-morbidities, surgical details, and operative mortality of the patient population are reported in Table 1 . Within this series, age, EF, age/EF ratio, serum creatinine > 2 mg/dL, pre-operative HCT, and emergency operation were significantly associated with the operative mortality at the univariate analysis ( Table 2 ). The operative mortality rate was 20.5% (53 cases) in the 259 patients with serum creatinine > 2.0 mg/dL and 3.1% (207 cases) in the 6752 patients with serum creatinine < _ 2.0 mg/dL (relative risk 8.1, 95% CI 5.8-11.3, P = 0.001). Two-hundred andthirtysix non-emergency patients died out of 6903 cases ( The pre-operative HCT was associated with operative mortality with an OR of 0.86 (95% CI 0.84-0.88, P = 0.001). The logistic equation for operative mortality at different values of pre-operative HCT is reported in Figure 1 . The discrimination properties of the HCT as a determinant of operative mortality were investigated with an ROC analysis. The c-statistics is 0.692 (95% CI 0.68-0.703). Adequate cutoff values were searched, and the best combination of specificity and sensitivity was found at an HCT value of 36% (sensitivity 54%, specificity 78%, and Youden index J: 0.322). Operative mortality in patients with a pre-operative HCT > _ 36 (n = 5180) was 2.2%, and in patients with a pre-operative HCT < 36% (n = 1831) was 8.0% (relative risk 3.9, 95% CI 3.0-5.0, P = 0.001). Therefore, for the subsequent analyses, the pre-operative HCT was considered a risk factor for operative mortality if <36%, and the level of anaemia was expressed in terms of HCT (%) difference (36-actual HCT value).
In analogy with our original work, 1 the model for the ACEF II started with the age/EF ratio. This variable alone yielded a c-statistics of 0.738 (95% CI 0.71-0.77). Subsequently, the other three factors (serum creatinine > 2.0 mg/dL, emergency surgery, and HCT points below 36%) were entered into a multivariable logistic regression model for operative mortality shown in Table 3 . All the factors were confirmed as independent predictors of operative mortality. Based on the relative Haematocrit values of 36% or higher count as zero and make null the last term of the equation. In our series, the ACEF II score is stratified between a minimum value of 0.23 and a maximum value of 10.5
The relationship between the ACEF II and the operative mortality is defined by the logistic equation: 
ACEF II calibration
In the total patient population, the predicted operative mortality rate according to the ACEF II was 3.73%, not significantly different from the observed operative mortality rate (3.71%, 95% CI 3.25-4.15%). The Hosmer-Lemeshow test showed a good overall calibration (v2 10.33, P = 0.243). Table 4 reports the predicted and observed operative mortality rates according to the ACEF and the ACEF II score in the overall population and for separate groups according to the presence of the additional factors (emergency and HCT < 36%). In the overall patient population, both the ACEF and the ACEF II predicted operative are within the 95% CI of the observed operative mortality, however, with a better calibration of the ACEF II. When excluding emergency surgery (like in the original ACEF dataset), both the scores are well calibrated. In the low-risk patient population (no anaemia/emergency), the ACEF overestimated the operative mortality risk, while the ACEF II was correctly calibrated. In the anaemic subgroup, the ACEF underestimated the operative mortality risk, while the ACEF II was well calibrated. Finally, in the subgroups at high risk (emergency cases and emergency þ anaemia), the ACEF underestimated the operative mortality risk, while the ACEF II had a better calibration. However, the relatively low sample size limits the statistical value of this last analysis. Figure 5 reports the calibration plot of the development series. Overall, there is a good calibration for predicted operative mortality rates until 35%, with an intercept of the linear regression line of 0.006. For predicted operative mortality rates exceeding 35%, the predicted risk exceeds the observed operative mortality, leading to a slope of the linear regression relationship of 0.83, moderately below the theoretical perfect value of 1.0. Triangles represent the observed operative mortality at seven incremental predicted operative mortality points: < _3.0% (5186 cases); >3.0% and < _5.0% (935 cases); >5.0% and < _10% (473 cases); >10% and < _15%, (158 cases); >15% and < _25% (140 cases); >25% and < _50% (93 cases); >50% (26 cases). (A) intercept with the y axis; (B) slope of the regression line. CI, confidence interval. The ACEF II risk score for cardiac surgery the ACEF II score. The discrimination was significantly (P = 0.007) better with the ACEF II score (c-statistics 0.760, 95% CI 0.731-0.793) than with the ACEF score (c-statistics 0.681, 95% CI 0.653-0.701) ( Figure 6 ). The predicted operative mortality rate in this series was 4.17% (95% CI 3.8-4.5%) and the observed operative mortality rate was 4.21% (95% CI 3.3-5.2%). The Hosmer-Lemeshow test demonstrated a good overall calibration, with a v2 of 7.36 (P = 0.498).
External validation
Discussion
To be effective and applicable in daily clinical practice, risk scores should be intended as dynamic tools. In the setting of patients with cardiac disease, this concept is particularly important, because of the rapid changes in therapeutic options, techniques, new drugs availability, and in the pattern of the patient population. The route toward a periodic update has been successfully followed by the EuroSCORE II and by the STS score, that is continuously updated based on the overwhelming amount of patients available in the development dataset. After 7 years from its original publication, the ACEF score deserved a similar process, and the resulting ACEF II seems now more adequate to the patient population of today. The main changes with respect to the ACEF are (i) a re-modulation of the relative weight attributed to age/EF and serum creatinine > 2.0 mg/dL, (ii) the applicability to emergency cardiac surgery, and (iii) the inclusion of pre-operative anaemia as an additional risk factor. Given these changes, the ACEF II does not betray its original philosophy, based on the law of parsimony of William of Occam (14th century): Among competing hypotheses, the one with the fewest assumptions should be selected and John Punch (17th century): Entities must not be multiplied beyond necessity.
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In our series, and even in an external validation series, the ACEF II proved a better discrimination and calibration if compared with the original ACEF.
With respect to the ACEF, the ACEF II presents a number of novelties. The 1st one pertains the role of ACEF in determining the operative mortality risk. The combination of the two factors (age and EF) in the development series (2010-16) seems less relevant for the global risk determination with respect to the original series (2000-09).
Solving the logistic equations of the ACEF and ACEF II for a patient aged 80 years with an EF of 30% and no additional risk factors provides an operative mortality risk of 10.8% for the ACEF and 5.39% for the ACEF II. This 50% absolute reduction of the operative mortality risk reflects well what happened with the EuroSCORE II with respect to the EuroSCORE. The great part of this change should be attributed to a lower relative weight of the EF: an 80-year-old patient with an EF of 60% has only a minor predicted risk reduction from 2.27% (ACEF) to 2.06% (ACEF II).
A serum creatinine level > 2.0 mg/dL remains an important risk factor in the ACEF II. Its contribution to the global risk prediction appears increased: according to the ACEF, a 60-year-old patient with an EF of 50% had a predicted operative mortality risk of 1.94% which raised to 6.4% (3.3 times higher) in presence of a serum creatinine > 2.0 mg/dL. According to the ACEF II, the same patient has a predicted operative mortality of 1.87%, raising to 7.87% (4.2 times higher) in the presence of a serum creatinine > 2.0 mg/dL.
Therefore, it appears that the evolving scenario of cardiac surgery during the last years has increased the ability of the clinicians to cope with elderly patients and impaired left ventricular contractility. Conversely, the renal function deterioration, being a marker of the systemic effects of the cardiac disease and namely of the organ dysfunction in the presence of chronic or acute heart failure, maintains and even increases its contribution to the global operative mortality risk.
The inclusion of emergency cardiac surgery in the ACEF II provides a larger applicability, even if it must be underlined that our development series included only 1.5% of patients operated under emergency conditions (strictly defined as an operation required before the beginning of the next working day after decision to operate). Overall, emergency surgery is a strong multiplier of the operative mortality risk (7-8 higher than in patients operated under elective conditions). When considering this important factor, it should be underscored that this is the only 'arbitrary' definition included in the model. For homogeneity purposes, we have applied a definition which exactly matches that of the EuroSCORE II. However, other definitions exist. The STS score defines emergency surgery as 'surgery should not be delayed'. Different definitions of course determine different adjudication criteria, and this should be considered when comparing the STS score with the ACEF II score. The same caution should be applied in comparing the calibration properties of the EuroSCORE II and the ACEF II: the first is targeted to in-hospital mortality, whereas the second considers even after discharge mortality if it occurs within 30 days from surgery. This accounts for a difference that is in the range of 0.6%. 11 The inclusion of anaemia (defined as a pre-operative HCT < 36%) in a mortality risk score is a (relative) novelty. Both the EuroSCORE II and the STS score do not include this parameter; however, it must be recognized that the progenitor of modern risk scores for coronary surgery (the Clinical Severity Score from Higgins and associates) 23 since 1992 included an HCT < 34% within a cohort of risk factors contributing to the total mortality risk prediction. During the last years, many studies found an association between anaemia and mortality in cardiac surgery, [14] [15] [16] [17] [18] and a recent meta-analysis pooling together 10 observational studies found an OR for mortality of 2.98 (95% CI 2.02-4.38) in anaemic patients undergoing cardiac surgery. 24 In our model, we decided not to dichotomize this risk factor (anaemic/non-anaemic) but rather to consider it in its natural continuous distribution, attributing 0.2 ACEF II score points to each 1% HCT value below 36%. This allows taking into account the obvious differences in risk stratification for patients with different degrees (from mild to moderate to severe) of pre-operative anaemia. The resulting effects of anaemia on operative mortality risk prediction are reasonably within the range found in the above quoted meta-analysis 24 : according to the ACEF II a 60-year patient with 40% EF and an HCT > _ 36% has an operative mortality risk of 2.33%, which raises to 5.55% (relative risk 2.4) if the HCT is 30%.
Different interpretations (which certainly are outside the purposes of the present study) may be advocated to justify the role of anaemia as a risk factor for mortality in cardiac surgery patients. We are inclined to consider anaemia (in analogy with renal function impairment) as a comprehensive marker of the systemic effects of the cardiac disease and namely of heart failure and renal dysfunction (the vicious circle of cardio-renal-anaemia syndrome). Other mechanisms that could be advocated include nutritional deficiency and iron deficiency that are common in the elderly population. In a parsimonious model like the ACEF II, anaemia is an independent operative mortality risk factor. In more complex models, the exclusion of anaemia unveils a non-independent association with mortality. This is very likely due to the inclusion of a number of specific risk factors, which are representative of the systemic effects of the cardiac disease (NYHA class, poor mobility, critical pre-operative state, recent myocardial infarction, class 4 angina. . .) and which are inter-correlated with anaemia.
Giving dignity to anaemia in the setting of cardiac surgery involves some important consequences. Anaemia is a modifiable risk factor, and iron supplementation has been suggested, even if still unproven, for the treatment of anaemic patients undergoing cardiac surgery. 25 The ACEF II may be a useful tool to stratify the operative risk with and without anaemia correction, and to verify the real efficacy of this approach.
In conclusion, far from claiming superiority to the other existing risk scores, the ACEF II score presents itself as a still parsimonious, more comprehensive, and updated tool for operative mortality risk stratification in cardiac surgery, waiting for adequately sized external series to undergo the imperative validation process.
